VHT is trading 3.08% up today as healthcare attracts defensive rotation and positive late-stage melanoma-vaccine results from Moderna and Merck lift sector sentiment.
- Treasury yields eased modestly before the 2:00 p.m. ET FOMC minutes, supporting equities amid technology weakness.
- The move appears sector-driven, not tied to VHT’s BioMarin-Alesta transaction; healthcare leadership also cushioned the August 18 market selloff.